Heico Corp: Form 10-Q for the period ended Apr 30, 2022
Filed with the SEC on May 25, 2022 and accepted by EDGAR at May 25, 2022, 16:21 ET.
Management's discussion and analysis
As filed, 30,560 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
This discussion of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and notes thereto included herein. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates if different assumptions were used or different events ultimately transpire.
Our critical accounting policies, which require management to make judgments about matters that are inherently uncertain, are described in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” under the heading “Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended October 31, 2021. There have been no material changes to our critical accounting policies during the six months ended April 30, 2022.
Our business is comprised of two operating segments: the Flight Support Group (“FSG”), consisting of HEICO Aerospace Holdings Corp. and HEICO Flight Support Corp. and their respective subsidiaries; and the Electronic Technologies Group (“ETG”), consisting of HEICO Electronic Technologies Corp. and its subsidiaries.
Our results of operations in fiscal 2022 continue to reflect the adverse impact from the COVID-19 global pandemic (the “Pandemic”). Despite the aforementioned, we experienced continued improvement in operating results in the first six months and second quarter of fiscal 2022 as compared to the first six months and second quarter of fiscal 2021 principally reflecting improved demand for our commercial aerospace products. The Flight Support Group has reported seven consecutive quarters of improvement in net sales and operating income resulting from signs of commercial air travel recovery in certain domestic travel markets, moderated by a slower recovery in international travel markets.
Additionally, our results of operations for the six and three months ended April 30, 2022 have been affected by the fiscal 2021 acquisitions as further detailed in Note 2, Acquisitions, of the Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the year ended October 31, 2021 and the fiscal 2022 acquisitions as further detailed in Note 2, Acquisitions, of the Notes to the Condensed Consolidated Financial Statements of this quarterly report.
Results of Operations
The following table sets forth the results of our operations, net sales and operating income by segment and the percentage of net sales represented by the respective items in our Condensed Consolidated Statements of Operations (in thousands):
| Six months ended April 30, 2022 | 2021 | Three months ended April 30, 2022 | 2021 | |
|---|---|---|---|---|
| Net sales | $1,029,156 | $884,553 | $538,813 | $466,651 |
| Cost of sales | 627,717 | 546,346 | 327,584 | 286,878 |
| Selling, general and administrative expenses | 179,840 | 161,174 | 88,452 | 83,025 |
| Total operating costs and expenses | 807,557 | 707,520 | 416,036 | 369,903 |
| Operating income | $221,599 | $177,033 | $122,777 | $96,748 |
| Net sales by segment: | ||||
| Flight Support Group | $578,994 | $429,614 | $306,313 | $230,280 |
| Electronic Technologies Group | 459,729 | 466,639 | 237,393 | 243,089 |
| Intersegment sales | (9,567) | (11,700) | (4,893) | (6,718) |
| $1,029,156 | $884,553 | $538,813 | $466,651 | |
| Operating income by segment: | ||||
| Flight Support Group | $118,573 | $61,298 | $66,197 | $35,476 |
| Electronic Technologies Group | 121,576 | 131,422 | 65,988 | 71,294 |
| Other, primarily corporate | (18,550) | (15,687) | (9,408) | (10,022) |
| $221,599 | $177,033 | $122,777 | $96,748 | |
| Net sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Gross profit | 39.0% | 38.2% | 39.2% | 38.5% |
| Selling, general and administrative expenses | 17.5% | 18.2% | 16.4% | 17.8% |
| Operating income | 21.5% | 20.0% | 22.8% | 20.7% |
| Interest expense | .2% | .5% | .2% | .4% |
| Other income | .1% | .1% | .1% | .1% |
| Income tax expense | 3.2% | 2.4% | 5.4% | 4.0% |
| Net income attributable to noncontrolling interests | 1.5% | 1.3% | 1.5% | 1.2% |
| Net income attributable to HEICO | 16.7% | 16.0% | 15.8% | 15.1% |
25
Comparison of First Six Months of Fiscal 2022 to First Six Months of Fiscal 2021
Net Sales
Our consolidated net sales in the first six months of fiscal 2022 increased by 16% to a record $1,029.2 million, up from net sales of $884.6 million in the first six months of fiscal 2021. The increase in consolidated net sales principally reflects an increase of $149.4 million (a 35% increase) to $579.0 million in net sales within the FSG, partially offset by a decrease of $6.9 million (a 1% decrease) to $459.7 million in net sales within the ETG. The net sales increase in the FSG reflects strong organic growth of 26% as well as net sales of $36.3 million contributed by our fiscal 2021 and 2022 acquisitions. The FSG's organic growth reflects increased demand for the majority of our commercial aerospace products and services resulting from continued recovery in global commercial air travel as compared to the prior year. As such, organic net sales increased by $62.8 million, $30.5 million and $19.8 million within our aftermarket replacement parts, repair and overhaul parts and services and specialty products product lines, respectively. The net sales decrease in the ETG principally reflects a 3% decrease in organic net sales, partially offset by $10.4 million contributed by our fiscal 2021 and 2022 acquisitions. The ETG's organic net sales decline is mainly attributable to decreased demand for our defense products resulting in a net sales decrease of $36.7 million, partially offset by increased demand for our medical, other electronics, telecommunications and space products resulting in net sales increases of $9.2 million, $4.9 million, $3.3 million and $2.2 million, respectively. Although sales price changes were not a significant contributing factor to the change in net sales of the FSG and ETG in the first six months of fiscal 2022, recent cost inflation and potential supply chain disruptions may lead to higher sales prices during the remainder of fiscal 2022.
Gross Profit and Operating Expenses
Our consolidated gross profit margin increased to 39.0% in the first six months of fiscal 2022, up from 38.2% in the first six months of fiscal 2021, principally reflecting a 3.8% improvement in the FSG's gross profit margin, partially offset by a .6% decrease in the ETG's gross profit margin. The increase in the FSG's gross profit margin principally reflects the previously mentioned higher net sales across all product lines. The reduction in the ETG's gross profit margin principally reflects the decrease in net sales of defense products and an increase in new product research and development expenses as a percentage of net sales to support ongoing new product research and development activities. Total new product research and development expenses included within our consolidated cost of sales were $37.1 million in the first six months of fiscal 2022, up from $34.2 million in the first six months of fiscal 2021.
Our consolidated selling, general and administrative ("SG&A") expenses were $179.8 million in the first six months of fiscal 2022, as compared to $161.2 million in the first six months of fiscal 2021. The increase in consolidated SG&A expenses principally reflects costs incurred to support the previously mentioned net sales growth resulting in increases of $6.3 million and $6.1 million in general and administrative expenses and selling expenses, respectively. Additionally, the increase in consolidated SG&A expenses reflects $6.3 million attributable to our fiscal 2021 and 2022 acquisitions.
Our consolidated SG&A expenses as a percentage of net sales decreased to 17.5% in the first six months of fiscal 2022, down from 18.2% in the first six months of fiscal 2021. The decrease in consolidated SG&A expenses as a percentage of net sales principally reflects the efficiencies realized from the higher net sales, as a well as a .4% impact from lower intangible asset amortization expense and a .2% favorable impact from changes in the estimated fair value of accrued contingent consideration.
Operating Income
Our consolidated operating income increased by 25% to a record $221.6 million in the first six months of fiscal 2022, up from $177.0 million in the first six months of fiscal 2021. The increase in consolidated operating income principally reflects a $57.3 million increase (a 93% increase) to a record $118.6 million in operating income of the FSG, partially offset by a $9.8 million decrease (a 7% decrease) to $121.6 million in operating income of the ETG. The increase in operating income of the FSG principally reflects the previously mentioned improved gross profit margin, net sales growth, and efficiencies realized from the higher net sales volume. The decrease in operating income of the ETG principally reflects a lower level of efficiencies resulting from the net sales decrease, as well as the previously mentioned lower gross profit margin. Further, the increase in consolidated operating income was partially offset by $4.5 million of higher corporate expenses mainly attributable to an increase in performance-based compensation expense and the suspension of corporate salary reductions as of the end of the first quarter of fiscal 2021.
Our consolidated operating income as a percentage of net sales increased to 21.5% in the first six months of fiscal 2022, up from 20.0% in the first six months of fiscal 2021. The increase principally reflects an increase in the FSG’s operating income as a percentage of net sales to 20.5% in the first six months of fiscal 2022, up from 14.3% in the first six months of fiscal 2021, partially offset by a decrease in the ETG's operating income as a percentage of net sales to 26.4% in the first six months of fiscal 2022, as compared to 28.2% in the first six months of fiscal 2021. The increase in the FSG’s operating income as a percentage of net sales principally reflects the previously mentioned improved gross profit margin, as well as a 2.4% impact from a decrease in SG&A expenses as a percentage of net sales mainly reflecting the previously mentioned efficiencies. The decrease in the ETG's operating income as a percentage of net sales principally reflects a 1.1% impact from an increase in SG&A expenses as a percentage of net sales mainly from the previously mentioned lower level of efficiencies, as well as the previously mentioned lower gross profit margin.
Interest Expense
Interest expense decreased to $1.8 million in the first six months of fiscal 2022, down from $4.5 million in the first six months of fiscal 2021. The decrease was principally due to a lower weighted average balance of borrowings outstanding under our revolving credit facility.
Other Income
Other income in the first six months of fiscal 2022 and 2021 was not material.
Income Tax Expense
Our effective tax rate was 15.0% in the first six months of fiscal 2022, as compared to 12.0% in the first six months of fiscal 2021. The increase in our effective tax rate principally reflects an unfavorable impact from tax-exempt unrealized losses in the cash surrender values of life insurance policies related to the HEICO Leadership Compensation Plan ("HEICO LCP") in the first six months of fiscal 2022 as compared to the tax-exempt unrealized gains recognized on such policies in the first six months of fiscal 2021, partially offset by a larger tax benefit from stock option exercises recognized in the first quarter of fiscal 2022. We recognized a discrete tax benefit from stock option exercises in both the first quarter of fiscal 2022 and 2021 of $17.8 million and $13.5 million, respectively. The tax benefit from stock option exercises in both periods was the result of strong appreciation in HEICO's stock price during the optionees' holding periods.
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests relates to the 20% noncontrolling interest held by Lufthansa Technik AG in HEICO Aerospace Holdings Corp. and the noncontrolling interests held by others in certain subsidiaries of the FSG and ETG. Net income attributable to noncontrolling interests was $15.4 million in the first six months of fiscal 2022, as compared to $11.5 million in the first six months of fiscal 2021. The increase in net income attributable to noncontrolling interests principally reflects improved operating results of certain subsidiaries of the FSG in which noncontrolling interests are held, inclusive of fiscal 2021 and 2022 acquisitions, partially offset by a decrease in the operating results of certain subsidiaries of the ETG in which noncontrolling interests are held.
Net Income Attributable to HEICO
Net income attributable to HEICO increased by 22% to $171.9 million, or $1.25 per diluted share, in the first six months of fiscal 2022, up from $141.3 million, or $1.03 per diluted share, in the first six months of fiscal 2021 principally reflecting the previously mentioned higher consolidated operating income.
Comparison of Second Quarter of Fiscal 2022 to Second Quarter of Fiscal 2021
Net Sales
Our consolidated net sales in the second quarter of fiscal 2022 increased by 15% to $538.8 million, up from net sales of $466.7 million in the second quarter of fiscal 2021. The increase in consolidated net sales principally reflects an increase of $76.0 million (a 33% increase) to $306.3 million in net sales within the FSG, partially offset by a decrease of $5.7 million (a 2% decrease) to $237.4 million in net sales within the ETG. The net sales increase in the FSG reflects strong organic growth of 23% as well as net sales of $22.7 million contributed by our fiscal 2021 and 2022 acquisitions. The FSG's organic growth reflects increased demand for the majority of our commercial aerospace products and services resulting from continued recovery in global commercial air travel as compared to the prior year. As such, organic net sales increased by $30.3 million, $12.2 million and $10.8 million within our aftermarket replacement parts, repair and overhaul parts and services and specialty products product lines, respectively. The net sales decrease in the ETG principally reflects a 4% decrease in organic net sales, partially offset by $5.2 million contributed by our fiscal 2021 and 2022 acquisitions. The ETG's organic net sales decline is mainly attributable to decreased demand for our defense products resulting in a net sales decrease of $22.1 million, partially offset by increased demand for our space, medical, other electronics and telecommunications products resulting in net sales increases of $4.4 million, $4.2 million, $2.1 million and $1.9 million, respectively. Although sales price changes were not a significant contributing factor to the change in net sales of the FSG and ETG in the second quarter of fiscal 2022, recent cost inflation and potential supply chain disruptions may lead to higher sales prices during the remainder of fiscal 2022.
Gross Profit and Operating Expenses
Our consolidated gross profit margin increased to 39.2% in the second quarter of fiscal 2022, up from 38.5% in the second quarter of fiscal 2021, principally reflecting a 3.4% improvement in the FSG's gross profit margin, partially offset by a .4% decrease in the ETG's gross profit margin. The increase in the FSG's gross profit margin principally reflects the previously mentioned higher net sales across all product lines. The reduction in the ETG's gross profit margin principally reflects the decrease in net sales of defense products and an increase in new product research and development expenses as a percentage of net sales to support ongoing new product research and development activities. Total new product research and development expenses included within our consolidated cost of sales were $18.8 million in the second quarter of fiscal 2022, up from $18.0 million in the second quarter of fiscal 2021.
Our consolidated SG&A expenses were $88.5 million in the second quarter of fiscal 2022, as compared to $83.0 million in the second quarter of fiscal 2021. The increase in consolidated SG&A expenses principally reflects $3.4 million attributable to our fiscal 2021 and 2022 acquisitions and an increase of $3.1 million in selling expenses to support the previously mentioned net sales growth, partially offset by a $1.1 million decrease in general and administrative expenses.
Our consolidated SG&A expenses as a percentage of net sales decreased to 16.4% in the second quarter of fiscal 2022, down from 17.8% in the second quarter of fiscal 2021. The decrease in consolidated SG&A expenses as a percentage of net sales principally reflects the efficiencies realized from the higher net sales, as well as a .6% impact from lower accrued performance-based compensation expense, a .4% favorable impact from changes in the estimated fair value of accrued contingent consideration, and a .3% impact from lower intangible asset amortization expense.
Operating Income
Our consolidated operating income increased by 27% to a record $122.8 million in the second quarter of fiscal 2022, up from $96.7 million in the second quarter of fiscal 2021. The increase in consolidated operating income principally reflects a $30.7 million increase (an 87% increase) to a record $66.2 million in operating income of the FSG, partially offset by a $5.3 million decrease (a 7% decrease) to $66.0 million in operating income of the ETG. The increase in operating income of the FSG principally reflects the previously mentioned net sales growth, improved gross profit margin, and efficiencies realized from the higher net sales volume. The decrease in operating income of the ETG principally reflects a lower level of efficiencies resulting from the net sales decrease, as well as the previously mentioned lower gross profit margin.
Our consolidated operating income as a percentage of net sales increased to 22.8% in the second quarter of fiscal 2022, up from 20.7% in the second quarter of fiscal 2021. The increase principally reflects an increase in the FSG’s operating income as a percentage of net sales to 21.6% in the second quarter of fiscal 2022, up from 15.4% in the second quarter of fiscal 2021, partially offset by a decrease in the ETG's operating income as a percentage of net sales to 27.8% in the second quarter of fiscal 2022, as compared to 29.3% in the second quarter of fiscal 2021. The increase in the FSG’s operating income as a percentage of net sales principally reflects the previously mentioned improved gross profit margin, as well as a 2.9% impact from a decrease in SG&A expenses as a percentage of net sales mainly reflecting the previously mentioned efficiencies. The decrease in the ETG's operating income as a percentage of net sales principally reflects a 1.1% impact from an increase in SG&A expenses as a percentage of net sales mainly from the previously mentioned lower level of efficiencies, as well as the previously mentioned lower gross profit margin.
Interest Expense
Interest expense decreased to $1.0 million in the second quarter of fiscal 2022, down from $2.1 million in the second quarter of fiscal 2021. The decrease was principally due to a lower weighted average balance of borrowings outstanding under our revolving credit facility.
Other Income
Other income in the second quarter of fiscal 2022 and 2021 was not material.
Income Tax Expense
Our effective tax rate was 23.7% in the second quarter of fiscal 2022, as compared to 19.5% in the second quarter of fiscal 2021. The increase in our effective tax rate principally reflects an unfavorable impact from tax-exempt unrealized losses in the cash surrender values of life insurance policies related to the HEICO LCP in the second quarter of fiscal 2022 as compared to the tax-exempt unrealized gains recognized on such policies in the second quarter of fiscal 2021.
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests relates to the 20% noncontrolling interest held by Lufthansa Technik AG in HEICO Aerospace Holdings Corp. and the noncontrolling interests held by others in certain subsidiaries of the FSG and ETG. Net income attributable to noncontrolling interests was $8.1 million in the second quarter of fiscal 2022, as compared to $5.8 million in the second quarter of fiscal 2021. The increase in net income attributable to noncontrolling interests principally reflects improved operating results of certain subsidiaries of the FSG in which noncontrolling interests are held, inclusive of fiscal 2021 and 2022 acquisitions.
Net Income Attributable to HEICO
Net income attributable to HEICO increased by 20% to $85.0 million, or $.62 per diluted share, in the second quarter of fiscal 2022, up from $70.7 million, or $.51 per diluted share, in the second quarter of fiscal 2021 principally reflecting the previously mentioned higher consolidated operating income.
Outlook
As we look ahead to the remainder of fiscal 2022, we expect global commercial air travel to continue growing despite the potential for additional Pandemic variants. We remain cautiously optimistic that the ongoing worldwide rollout of Pandemic vaccines, including boosters, will continue to positively influence global commercial air travel and benefit the markets we serve. But, it still remains very difficult to predict the Pandemic's path and effect, including factors like new variants and vaccination rates, potential supply chain disruptions and inflation, which can impact our key markets. Therefore, we feel it would not be responsible to provide fiscal 2022 net sales and earnings guidance at this time. However, we believe our ongoing conservative policies, strong balance sheet, and high degree of liquidity enable us to continuously invest in new research and development, take advantage of periodic strategic inventory purchasing opportunities, and execute on our successful acquisition program, which collectively position HEICO for market share gains.
Liquidity and Capital Resources
Our principal uses of cash include acquisitions, capital expenditures, cash dividends, distributions to noncontrolling interests and working capital needs. We now anticipate fiscal 2022 capital expenditures to be approximately $40 million. We finance our activities primarily from our operating and financing activities, including borrowings under our revolving credit facility. The revolving credit facility contains both financial and non-financial covenants. As of April 30, 2022, we were in compliance with all such covenants and our total debt to shareholders’ equity ratio was 11.0%.
On April 7, 2022, we entered into an amendment to extend the maturity date of our Revolving Credit Facility Agreement ("Credit Facility") by one year to November 2024 and to replace the Eurocurrency Rate with Adjusted Term SOFR as an election in which borrowings under the Credit Facility accrue interest, as such capitalized terms are defined in the Credit Facility.
Based on our current outlook, we believe that our net cash provided by operating activities and available borrowings under our revolving credit facility will be sufficient to fund cash requirements for at least the next twelve months.
Operating Activities
Net cash provided by operating activities was $174.8 million in the first six months of fiscal 2022 and consisted primarily of net income from consolidated operations of $187.4 million, depreciation and amortization expense of $46.7 million (a non-cash item), net changes in other long-term liabilities and assets related to the HEICO LCP of $13.4 million (principally participant deferrals and employer contributions), $6.9 million in share-based compensation expense (a non-cash item), and $5.4 million in employer contributions to the HEICO Savings and Investment Plan (a non-cash item), partially offset by an $87.4 million increase in net working capital. The increase in net working capital is inclusive of a $42.8 million increase in inventories reflecting strategic buys within our distribution businesses and to support an increase in consolidated backlog, a $20.3 million increase in accounts receivable resulting from the previously mentioned net sales growth, a $15.9 million decrease in accrued expenses and other current liabilities mainly reflecting the payment of fiscal 2021 accrued performance-based compensation, and a $9.0 million increase in prepaid expenses and other current assets.
Net cash provided by operating activities decreased by $35.4 million in the first six months of fiscal 2022 from $210.1 million in the first six months of fiscal 2021. The decrease is principally attributable to a $83.8 million increase in net working capital, partially offset by a $34.6 million increase in net income from consolidated operations, a $10.6 million decrease in deferred income tax benefits and a $2.6 million increase in share-based compensation expense. The increase in net working capital primarily resulted from the previously mentioned increase in inventories, the payment of a larger amount of accrued performance-based compensation in the first six months of fiscal 2022 resulting from the much improved fiscal 2021 operating results, and the increase in accounts receivable as a result of the previously mentioned net sales growth.
Investing Activities
Net cash used in investing activities totaled $144.0 million in the first six months of fiscal 2022 and related primarily to acquisitions of $105.5 million, capital expenditures of $16.2 million, investments related to the HEICO LCP of $11.7 million, and $10.5 million of other investing activities. Further details regarding our fiscal 2022 acquisitions may be found in Note 2, Acquisitions, of the Notes to Condensed Consolidated Financial Statements.
Financing Activities
Net cash used in financing activities in the first six months of fiscal 2022 totaled $18.1 million. During the first six months of fiscal 2022, we made $65.0 million in payments on our revolving credit facility, redeemed common stock related to stock option exercises aggregating $23.7 million, paid $12.2 million in cash dividends on our common stock, and made $10.6 million of distributions to noncontrolling interests, which were partially offset by $93.0 million of borrowings under our revolving credit facility.
Other Obligations and Commitments
There have not been any material changes to our other obligations and commitments that were included in our Annual Report on Form 10-K for the year ended October 31, 2021.
New Accounting Pronouncements
See Note 1, Summary of Significant Accounting Policies - New Accounting Pronouncements, of the Notes to Condensed Consolidated Financial Statements for additional information.
Forward-Looking Statements
Certain statements in this report constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained herein that are not clearly historical in nature may be forward-looking and the words “anticipate,” “believe,” “expect,” “estimate” and similar expressions are generally intended to identify forward-looking statements. Any forward-looking statement contained herein, in press releases, written statements or other documents filed with the Securities and Exchange Commission or in communications and discussions with investors and analysts in the normal course of business through meetings, phone calls and conference calls, concerning our operations, economic performance and financial condition are subject to risks, uncertainties and contingencies. We have based these forward-looking statements on our current expectations and projections about future events. All forward-looking statements involve risks and uncertainties, many of which are beyond our control, which may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. Also, forward-looking statements are based upon management’s estimates of fair values and of future costs, using currently available information. Therefore, actual results may differ materially from those expressed in or implied by those forward-looking statements. Factors that could cause such differences include: the severity, magnitude and duration of the Pandemic; our liquidity and the amount and timing of cash generation; lower commercial air travel caused by the Pandemic and its aftermath, airline fleet changes or airline purchasing decisions, which could cause lower demand for our goods and services; product specification costs and requirements, which could cause an increase to our costs to complete contracts; governmental and regulatory demands, export policies and restrictions, reductions in defense, space or homeland security spending by U.S. and/or foreign customers or competition from existing and new competitors, which could reduce our sales; our ability to introduce new products and services at profitable pricing levels, which could reduce our sales or sales growth; product development or manufacturing difficulties, which could increase our product development and manufacturing costs and delay sales; our ability to make acquisitions and achieve operating synergies from acquired businesses; customer credit risk; interest, foreign currency exchange and income tax rates; economic conditions, including the effects of inflation, within and outside of the aviation, defense, space, medical, telecommunications and electronics industries, which could negatively impact our costs and revenues; and defense spending or budget cuts, which could reduce our defense-related revenue. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.
Market risk
As filed, 260 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have not been any material changes in our assessment of HEICO’s sensitivity to market risk that was disclosed in Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the year ended October 31, 2021.
Controls and procedures
As filed, 876 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that HEICO’s disclosure controls and procedures are effective as of the end of the period covered by this quarterly report.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting during the second quarter ended April 30, 2022 that have materially affected, or are reasonably likely to materially affect, HEICO's internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-02-01 to 2022-04-30 | $538.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2021-11-01 to 2022-04-30 | $1.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-02-01 to 2022-04-30 | $327.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2021-11-01 to 2022-04-30 | $627.7m | us-gaap:CostOfRevenue |
| Research and development | 3 months2022-02-01 to 2022-04-30 | $18.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-11-01 to 2022-04-30 | $37.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-02-01 to 2022-04-30 | $88.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-11-01 to 2022-04-30 | $179.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-02-01 to 2022-04-30 | $122.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-11-01 to 2022-04-30 | $221.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-02-01 to 2022-04-30 | $29.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-11-01 to 2022-04-30 | $33.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-02-01 to 2022-04-30 | $85.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-11-01 to 2022-04-30 | $171.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-02-01 to 2022-04-30 | $0.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-11-01 to 2022-04-30 | $1.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-02-01 to 2022-04-30 | $0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-11-01 to 2022-04-30 | $1.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-02-01 to 2022-04-30 | 137,867,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-11-01 to 2022-04-30 | 137,916,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-11-01 to 2022-04-30 | $174.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-02-01 to 2022-04-30 | $7.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2021-11-01 to 2022-04-30 | $16.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2021-11-01 to 2022-04-30 | $12.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2022-04-30 | $117.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-04-30 | $1.03bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-04-30 | $3.69bn | us-gaap:Assets |
| Current liabilities | At period end2022-04-30 | $304.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-04-30 | $960.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-04-30 | $2.38bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000046619-22-000030. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.